The United Bio-technology (hengqin) Co., Ltd.
Clinical trials sponsored by The United Bio-technology (hengqin) Co., Ltd., explained in plain language.
-
New shot aims to heal scarred livers in major trial
Disease control Recruiting nowThis study is testing an investigational injection called UBT251 to see if it can improve liver health in adults with Metabolic Dysfunction-Associated Steatohepatitis (MASH), a serious form of fatty liver disease that causes inflammation and scarring. About 156 participants will …
Phase: PHASE2 • Sponsor: The United Bio-Technology (Hengqin) Co., Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New shot aims to shield kidneys and shed pounds
Disease control Recruiting nowThis study is testing whether an experimental injection called UBT251 can help protect kidney function and reduce body weight in adults who are overweight or obese and have chronic kidney disease. About 180 participants will receive either the UBT251 injection or a placebo (dummy…
Phase: PHASE2 • Sponsor: The United Bio-Technology (Hengqin) Co., Ltd. • Aim: Disease control
Last updated Feb 23, 2026 14:56 UTC